MYC and PIM2 Co-Expression in Mouse Bone Marrow Cells Readily Establishes Permanent Myeloid Cell Lines That Can Induce Lethal Myeloid Sarcoma In Vivo

Allen, 1997, Pim-2 transgene induces lymphoid tumors, exhibiting potent synergy with c-myc, Oncogene, 15, 1133, 10.1038/sj.onc.1201288

Brown, 1997, A PMLRA-Ralpha transgene initiates murine acute promyelocytic leukemia, Proc. Natl. Acad. Sci. USA, 94, 2551, 10.1073/pnas.94.6.2551

Cashman, 1997, Kinetic evidence of the regeneration of multilineage hematopoiesis from primitive cells in normal human bone marrow transplanted into immunodeficient mice, Blood, 89, 4307, 10.1182/blood.V89.12.4307

Chen, 2005, Pim family kinases enhance tumor growth of prostate cancer cells, Mol. Cancer Res, 3, 443, 10.1158/1541-7786.MCR-05-0007

Cheng, 1999, Distinct leukemia phenotypes in transgenic mice and different corepressor interactions generated by promyelocytic leukemia variant fusion genes PLZF-RARalpha and NPM-RARalpha, Proc. Natl. Acad. Sci. USA, 96, 6318, 10.1073/pnas.96.11.6318

Cuenco, 2000, Human AML1/ MDS1/EVI1 fusion protein induces an acute myelogenous leukemia (AML) in mice: a model for human AML, Proc. Natl. Acad. Sci. USA, 97, 1760, 10.1073/pnas.030421197

Deme, 1997, Granulocytic sarcoma of the spine in nonleukemic patients: report of three cases, Neurosurgery, 40, 1283, 10.1097/00006123-199706000-00031

Dick, 1997, Assay of human stem cells by repopulation of NOD/SCID mice, Stem Cells, 15, 199, 10.1002/stem.5530150826

Grisolano, 1994, Early myeloid cellspecific expression of the human cathepsin G gene in transgenic mice, Proc. Natl. Acad. Sci. USA, 91, 8989, 10.1073/pnas.91.19.8989

Grisolano, 1997, Altered myeloid development and acute leukemia in transgenic mice expressing PML-RAR alpha under control of cathepsin G regulatory sequences, Blood, 89, 376, 10.1182/blood.V89.2.376

Grisolano, 2003, An activated receptor tyrosine kinase, TEL/PDGFbetaR, cooperates with AML1/ETO to induce acute myeloid leukemia in mice, Proc. Natl. Acad. Sci. USA, 100, 9506, 10.1073/pnas.1531730100

Guzman, 2002, Preferential induction of apoptosis for primary human leukemic stem cells, Proc. Natl. Acad. Sci. USA, 99, 16220, 10.1073/pnas.252462599

Iversen, 2002, Inhibitors of angiogenesis selectively reduce the malignant cell load in rodent models of human myeloid leukemias, Leukemia, 16, 376, 10.1038/sj.leu.2402376

Kroon, 1998, Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b, EMBO J, 17, 3714, 10.1093/emboj/17.13.3714

Lapidot, 1997, Immune-deficient SCID and NOD/SCID mice models as functional assays for studying normal and malignant human hematopoiesis, J. Mol. Med, 75, 664, 10.1007/s001090050150

Lavau, 2000, Retrovirus-mediated gene transfer of MLL-ELL transforms primary myeloid progenitors and causes acute myeloid leukemias in mice, Proc. Natl. Acad. Sci. USA, 97, 10984, 10.1073/pnas.190167297

Lawrence, 1999, Frequent co-expression of the HOXA9 and MEIS1 homeobox genes in human myeloid leukemias, Leukemia, 13, 1993, 10.1038/sj.leu.2401578

Luo, 2005, c-Myc rapidly induces acute myeloid leukemia in mice without evidence of lymphoma-associated antiapoptotic mutations, Blood, 106, 2452, 10.1182/blood-2005-02-0734

Mizuki, 2003, Suppression of myeloid transcription factors and induction of STAT response genes by AML-specific Flt3 mutations, Blood, 101, 3164, 10.1182/blood-2002-06-1677

Ory, 1996, A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes, Proc. Natl. Acad. Sci. USA, 93, 11400, 10.1073/pnas.93.21.11400

Philpott, 1996, The use of 7-amino actinomycin D in identifying apoptosis: simplicity of use and broad spectrum of application compared with other techniques, Blood, 87, 2244, 10.1182/blood.V87.6.2244.bloodjournal8762244

Robbins, 1997, Increased probability of expression from modified retroviral vectors in embryonal stem cells and embryonal carcinoma cells, J. Virol, 71, 9466, 10.1128/jvi.71.12.9466-9474.1997

Schmid, 1994, A rapid method for measuring apoptosis and dual-color immunofluorescence by single laser flow cytometry, J. Immunol. Methods, 170, 145, 10.1016/0022-1759(94)90390-5

Thorsteinsdottir, 1999, The oncoprotein E2A-Pbx1a collaborates with Hoxa9 to acutely transform primary bone marrow cells, Mol. Cell. Biol, 19, 6355, 10.1128/MCB.19.9.6355

Wang, 2003, SCID-repopulating cell activity of human cord blood-derived CD34-cells assured by intra-bone marrow injection, Blood, 101, 2924, 10.1182/blood-2002-09-2782

Wang, 2010, Pim-2 phosphorylation of p21(Cip1/WAF1) enhances its stability and inhibits cell proliferation in HCT116 cells, Int. J. Biochem. Cell Biol, 42, 1030, 10.1016/j.biocel.2010.03.012

Wierenga, 2003, Differences in heat sensitivity between normal and acute myeloid leukemic stem cells: feasibility of hyperthermic purging of leukemic cells from autologous stem cell grafts, Exp. Hematol, 31, 421, 10.1016/S0301-472X(03)00049-3

Yang, 2011, Pim protein kinase-3 is regulated by TNF-alpha and promotes endothelial cell sprouting, Mol. Cells, 32, 235, 10.1007/s10059-011-1026-z

Yilmaz, 2006, Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells, Nature, 441, 475, 10.1038/nature04703

Yuan, 2001, AML1-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations, Proc. Natl. Acad. Sci. USA, 98, 10398, 10.1073/pnas.171321298

Zhang, 2006, PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention, Nature, 441, 518, 10.1038/nature04747

Zhang, 2008, Pim kinasedependent inhibition of c-Myc degradation, Oncogene, 27, 4809, 10.1038/onc.2008.123